Article info

Original research
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma

Authors

  • Katharina Filipski Neurological Institute (Edinger Institute), University Hospital, Frankfurt am Main, GermanyGerman Cancer Consortium (DKTK) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, GermanyFrankfurt Cancer Institute (FCI), Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Michael Scherer Department of Genetics, University of Saarland, Saarbrücken, GermanyMax Planck Institute for Informatics, Saarland Informatics Campus, Saarbrücken, GermanyGraduate School of Computer Science, Saarland Informatics Campus, Saabrücken, Germany PubMed articlesGoogle scholar articles
  • Kim N. Zeiner Department of Dermatology, University Hospital, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Andreas Bucher Department of Radiology, University Hospital, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Johannes Kleemann Department of Dermatology, University Hospital, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Philipp Jurmeister Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, GermanyInstitute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • Tabea I. Hartung Neurological Institute (Edinger Institute), University Hospital, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Markus Meissner Department of Dermatology, University Hospital, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Karl H. Plate Neurological Institute (Edinger Institute), University Hospital, Frankfurt am Main, GermanyGerman Cancer Consortium (DKTK) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, GermanyFrankfurt Cancer Institute (FCI), Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Tim R. Fenton School of Biosciences, University of Kent, Kent, UK PubMed articlesGoogle scholar articles
  • Jörn Walter Department of Genetics, University of Saarland, Saarbrücken, Germany PubMed articlesGoogle scholar articles
  • Sascha Tierling Department of Genetics, University of Saarland, Saarbrücken, Germany PubMed articlesGoogle scholar articles
  • Bastian Schilling Department of Dermatology, University Hospital Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Pia S. Zeiner German Cancer Consortium (DKTK) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, GermanyFrankfurt Cancer Institute (FCI), Frankfurt am Main, GermanyDr. Senckenberg Institute of Neurooncology, University Hospital, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Patrick N. Harter Neurological Institute (Edinger Institute), University Hospital, Frankfurt am Main, GermanyGerman Cancer Consortium (DKTK) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, GermanyFrankfurt Cancer Institute (FCI), Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Patrick N. Harter; patrick.harter{at}kgu.de
View Full Text

Citation

Filipski K, Scherer M, Zeiner KN, et al
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma

Publication history

  • Accepted June 25, 2021
  • First published July 19, 2021.
Online issue publication 
July 19, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.